Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Current Medicinal Chemistry|June 10, 2008
What does systems biology mean for drug development?André Schrattenholz, Vukić SoskićExperimental Gerontology|January 25, 2008
Nonenzymatic posttranslational protein modifications in ageingVukić Soskić, Karlfried Groebe, André SchrattenholzAnnals of the New York Academy of Sciences|June 12, 2010
Synchronization of posttranslational modifications during aging: Time is a crucial biological dimensionAndré Schrattenholz, Vukić Soskić, Karlfried GroebeProteomics|June 10, 2004
Brain proteome of mice lacking the receptors for tumor necrosis factor alphaVojislav Pejović, Vukić Soskić, Weihong Pan, et al.European Journal of Medicinal Chemistry|November 17, 2007
Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptorsDeana Andrić, Goran Roglić, Vladimir Sukalović, et al.Arzneimittel-Forschung|April 12, 2005
Interaction of arylpiperazines with the dopamine receptor D2 binding siteVladimir Sukalović, Mario Zlatović, Deana Andrić, et al.Archiv Der Pharmazie|September 1, 2007
1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptorsJelena Penjisević, Vladimir Sukalović, Deana Andrić, et al.Archiv Der Pharmazie|September 14, 2004
Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazinesVladimir Sukalović, Mario Zlatović, Deana Andrić, et al.Journal of Proteome Research|May 10, 2008
A connection between the mitochondrial permeability transition pore, autophagy, and cerebral amyloidogenesisVukić Soskić, Martina Klemm, Tassula Proikas-Cezanne, et al.Pageof 1